CP-547632 is primarily used in research settings as a selective inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2). It plays a significant role in studying angiogenesis, the process by which new blood vessels form from pre-existing vessels. By inhibiting VEGFR-2, CP-547632 helps researchers understand the mechanisms of tumor growth and metastasis, as angiogenesis is crucial for supplying nutrients and oxygen to cancer cells. This compound is also utilized in preclinical studies to evaluate its potential as an anticancer agent, particularly in targeting cancers that are heavily dependent on angiogenesis for progression. Additionally, CP-547632 aids in the development of therapeutic strategies aimed at blocking specific signaling pathways involved in various vascular diseases.